512 related articles for article (PubMed ID: 30128816)
21. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory, Antithrombotic and Cardiac Remodeling Preventive Effects of Eugenol in Isoproterenol-Induced Myocardial Infarction in Wistar Rat.
Mnafgui K; Hajji R; Derbali F; Gammoudi A; Khabbabi G; Ellefi H; Allouche N; Kadri A; Gharsallah N
Cardiovasc Toxicol; 2016 Oct; 16(4):336-44. PubMed ID: 26391896
[TBL] [Abstract][Full Text] [Related]
23. Effects of the vasopeptidase inhibitor omapatrilat on peri- and postmyocardial infarction in Zucker lean rats.
Lapointe N; Parker TG; Tsoporis JN; Nguyen QT; Marcotte F; Adam A; Lou I; Rouleau JL
Can J Cardiol; 2005 Mar; 21(3):291-7. PubMed ID: 15776120
[TBL] [Abstract][Full Text] [Related]
24. Effects of aldosterone receptor antagonist and angiotensin II type I receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction.
Matsumoto R; Yoshiyama M; Omura T; Kim S; Nakamura Y; Izumi Y; Akioka K; Iwao H; Takeuchi K; Yoshikawa J
Circ J; 2004 Apr; 68(4):376-82. PubMed ID: 15056838
[TBL] [Abstract][Full Text] [Related]
25. The novel Mas agonist, CGEN-856S, attenuates isoproterenol-induced cardiac remodeling and myocardial infarction injury in rats.
Savergnini SQ; Ianzer D; Carvalho MB; Ferreira AJ; Silva GA; Marques FD; Peluso AA; Beiman M; Cojocaru G; Cohen Y; Almeida AP; Rotman G; Santos RA
PLoS One; 2013; 8(3):e57757. PubMed ID: 23469229
[TBL] [Abstract][Full Text] [Related]
26. P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs.
Vilahur G; Gutiérrez M; Casani L; Lambert C; Mendieta G; Ben-Aicha S; Capdevila A; Pons-Lladó G; Carreras F; Carlsson L; Hidalgo A; Badimon L
Cardiovasc Res; 2018 Dec; 114(14):1860-1870. PubMed ID: 30124783
[TBL] [Abstract][Full Text] [Related]
27. Dihydrolycorine Attenuates Cardiac Fibrosis and Dysfunction by Downregulating Runx1 following Myocardial Infarction.
Ni T; Huang X; Pan S; Lu Z
Oxid Med Cell Longev; 2021; 2021():8528239. PubMed ID: 34725565
[TBL] [Abstract][Full Text] [Related]
28. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
[TBL] [Abstract][Full Text] [Related]
29. Cardiac-specific overexpression of diacylglycerol kinase zeta attenuates left ventricular remodeling and improves survival after myocardial infarction.
Niizeki T; Takeishi Y; Arimoto T; Takahashi H; Shishido T; Koyama Y; Goto K; Walsh RA; Kubota I
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1105-12. PubMed ID: 17071729
[TBL] [Abstract][Full Text] [Related]
30. Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure.
Yurista SR; Matsuura TR; Silljé HHW; Nijholt KT; McDaid KS; Shewale SV; Leone TC; Newman JC; Verdin E; van Veldhuisen DJ; de Boer RA; Kelly DP; Westenbrink BD
Circ Heart Fail; 2021 Jan; 14(1):e007684. PubMed ID: 33356362
[TBL] [Abstract][Full Text] [Related]
31. Roselle is cardioprotective in diet-induced obesity rat model with myocardial infarction.
Si LY; Ali SAM; Latip J; Fauzi NM; Budin SB; Zainalabidin S
Life Sci; 2017 Dec; 191():157-165. PubMed ID: 29066253
[TBL] [Abstract][Full Text] [Related]
32. Roselle attenuates cardiac hypertrophy after myocardial infarction
Si LY; Ramalingam A; Ali SS; Aminuddin A; Ng PY; Latip J; Kamisah Y; Budin SB; Zainalabidin S
EXCLI J; 2019; 18():876-892. PubMed ID: 31645847
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
Li Q; Xu Y; Li X; Guo Y; Liu G
Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
[TBL] [Abstract][Full Text] [Related]
34. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
Louhelainen M; Vahtola E; Forsten H; Merasto S; Kytö V; Finckenberg P; Leskinen H; Kaheinen P; Tikkanen I; Levijoki J; Mervaala E
J Hypertens; 2009 Oct; 27(10):2094-107. PubMed ID: 19730126
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.
Yin W; Zhang P; Huang JH; Zhang QY; Fan R; Li J; Zhou JJ; Hu YZ; Guo HT; Zhang SM; Wang YM; Kaye AD; Gu CH; Liu JC; Cheng L; Cui Q; Yi DH; Pei JM
Eur J Pharmacol; 2009 Apr; 607(1-3):135-42. PubMed ID: 19233160
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of microRNA-146a attenuated heart failure in myocardial infarction rats.
He J; Lu Y; Song X; Gong X; Li Y
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31763669
[TBL] [Abstract][Full Text] [Related]
37. Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway.
Chen X; Jiang X; Cheng C; Chen J; Huang S; Xu M; Liu S
Cardiovasc Drugs Ther; 2020 Aug; 34(4):463-473. PubMed ID: 32394178
[TBL] [Abstract][Full Text] [Related]
38. Protective effects of low-dose rosuvastatin on isoproterenol-induced chronic heart failure in rats by regulation of DDAH-ADMA-NO pathway.
Zhou R; Ma P; Xiong A; Xu Y; Wang Y; Xu Q
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27957828
[TBL] [Abstract][Full Text] [Related]
39. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
40. Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction.
Soeki T; Kishimoto I; Schwenke DO; Tokudome T; Horio T; Yoshida M; Hosoda H; Kangawa K
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H426-32. PubMed ID: 18024547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
